2 terminated. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Terminated 2 |
Follow Left Ventricular Hypertrophy: new trials by email Literature Review of Left Ventricular Hypertrophy trials Research Report on Left Ventricular Hypertrophy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effects of Levosimendan in Patients Eligible for Aortic Valve Replacement With Left Ventricular Hypertrophy levosimendan, placebo drug - Diastolic Dysfunction, Left Ventricular Hypertrophy | Phase 4 | Terminated | University of Aarhus | 20 | 2010-09-01 | 2018-12-03 |
| Active Vitamin D Effect on Left Ventricular Hypertrophy Alfacalcidiol - Chronic Kidney Disease, Secondary Hyperparathyroidism | Phase 4 | Terminated | Per Ivarsen | 24 | 2002-01-01 | 2015-12-08 |
Hypertrophy, Left Ventricular (2) · Aortic Valve Stenosis (1) · Heart Failure (1) · Hyperparathyroidism, Secondary (1) · Renal Insufficiency, Chronic (1)
Cardiomegaly (2) · Cardiovascular Diseases (2) · Heart Diseases (2) · Hypertrophy (2) · Pathological Conditions, Anatomical (2) · Pathological Conditions, Signs and Symptoms (2) · Aortic Valve Disease (1) · Chronic Disease (1) · Disease Attributes (1) · Endocrine System Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Heart Valve Diseases (1) · Hyperparathyroidism (1) · Kidney Diseases (1)
Simendan (1)
Per Ivarsen (1) · University of Aarhus (1)
Denmark (2)
Per Ivarsen, MD, PhD (1) · Peter Juhl-Olsen, M.D. (1)